Drug Type Small molecule drug |
Synonyms |
Mechanism 5-HT1A receptor partial agonists(Serotonin 1a (5-HT1a) receptor partial agonists), D2 receptor partial agonists(Dopamine D2 receptor partial agonists), D3 receptor partial agonists(Dopamine D3 receptor partial agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Depressive Disorder | Preclinical | CN | 09 Dec 2021 | |
Depressive Disorder | Preclinical | CN | 09 Dec 2021 | |
Schizophrenia | Preclinical | CN | 09 Dec 2021 | |
Schizophrenia | Preclinical | CN | 09 Dec 2021 |